# AusperBio Therapeutics, Inc. funding rounds and investors

As of 8 Nov 2026, AusperBio Therapeutics, Inc. has raised $343M across 5 verified rounds on record; latest: $120M Series C, announced 27 Aug 2026.

A startup developing therapeutics for chronic hepatitis B and other diseases

Website: https://ausperbio.com  
Headquarters: San Francisco, USA  
Page: https://fireround.dev/companies/ausperbio

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-08-27 | Series C | $120M | not stated | YuanBio Venture Capital, CDH Investments, Qiming Venture Partners, HanKang Capital, Sherpa Capital, InnoPinnacle Fund, RA Capital Management, L.P. ("RA Capital") | [ausperbio.com](https://ausperbio.com/news/2094324038209896449.html), [prnewswire.com](https://www.prnewswire.com/news-releases/ausperbio-completes-120-million-series-c-financing-to-advance-ahb-137-toward-potential-commercialization-and-expand-next-generation-hbv-therapies-302862321.html), [fiercebiotech.com](https://www.fiercebiotech.com/biotech/ausperbio-adds-120m-advance-hepatitis-b-therapy-through-ph3-and-commercialization) |
| 2025-09-22 | Series B | $63M | Qiming Venture Partners | HanKang Capital, CDH Investments, YuanBio Venture Capital, Sherpa Capital, Genesis Capital | [finsmes.com](https://www.finsmes.com/2025/09/ausperbio-raises-63m-in-series-b2-funding.html) |
| 2025-05-28 | Series B | $50 million | not stated | Qiming Venture Partners, CDH Investments, Genesis Capital, YuanBio Venture Capital, HanKang Capital, Sherpa Capital | [ausperbio.com](https://ausperbio.com/news/1928029090834657282.html) |
| 2024-12-26 | Series B | USD 73 million | HanKang Capital | Sherpa Capital, CDH Investments, Qiming Venture Partners, InnoPinnacle Fund, YuanBio Venture Capital | [prnewswire.com](https://www.prnewswire.com/news-releases/ausperbio-secures-73-million-in-series-b-financing-to-advance-functional-cure-for-chronic-hepatitis-b-302339451.html) |
| 2024-07-14 | Series A | $37 million | InnoPinnacle Fund | YuanBio Venture Capital, Qiming Venture Partners, HanKang Capital, Genesis Capital | [ausperbio.com](https://ausperbio.com/news/1812670488641626113.html), [prnewswire.com](https://www.prnewswire.com/news-releases/ausperbio-secures-37-million-in-series-a-financing-to-advance-ahb-137-clinical-development-for-hbv-cure-302196465.html) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.